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Long chain fatty acids (LCFAs) are an important source of 
energy for the body. Disruption of their plasma concentra-
tion is a determining factor in the onset and development of 
some diseases, mainly cardiovascular and metabolic ones. The 
membrane transport, which is the first step toward LCFA 
utilization consists of two components: diffusion “flip-flop”1 
and protein facilitated transfer, such as CD36.2 The altered 
expression of human CD36 is directly associated with dyslipi-
demia and the development of some cardiovascular diseases. 
For example, the CD36 deficiency among Japanese popula-
tion correlates with the development of hypertension, insulin 
resistance, and an abnormal concentration of plasma lipids.3,4 
CD36 polymorphisms were also shown to be correlated with 
dyslipidemia and abnormal concentration of FAs in Cauca-
sian populations.5 In vitro, lipid incorporation was altered in 
muscle and adipose tissues of CD36-null mice and SHRs.6,7
CD36 is highly expressed in tissues that require energy 
of FA oxidation, such as the heart and skeletal muscles.8,9 
CD36 is also expressed in adipose tissue10 and in pneumocytes 
characterized by the absorption of palmitic acid.11 CD36 is 
most abundant in proximal segments and in villi enterocytes, 
where most lipid absorption occurs.12 The tissue distribution 
of CD36, and the research cited above, confirm the role of this 
receptor in uptake and membrane transport of LCFAs. How-
ever, the non-resolution of the 3D structure of CD36 remains 
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a large hurdle in expanding studies on this protein. The first 
study to elucidate the CD36-FA binding site was done by 
Baillie et al,13 suggesting a potential site by utilizing a simple 
sequence alignment and without any validation.
The present study was designed to predict the 3D struc-
ture of CD36 [127–279 aa] based on homology modeling with 
the FABP-H.
Methods
Sequence retrieval. The target sequence 127–279 of 
CD36 was obtained from FASTA sequence of (CD36_
HUMAN) Platelet glycoprotein 4 with 472 amino acids (aa) 
encoded by P16671 in Uniprot database.14
Template identification and sequence alignment. 
The CD36 searched for similar sequence using the NCBI 
BLAST15 (Basic Local Alignment Search Tool). This search 
gave no significant results for the entire extracellular por-
tion [30–440 aa] of CD36 as the binding site for FAs pre-
dicted [127–279 aa], reason why we decided to choose FABPs 
(2FTB, 1FE3, 1HMT, 2FLJ, 1VYG, 1ADL, 1O8V, 1B56, 
2IFB) (Table 1) which have the same characteristic to bind 
LCFAs but showed alignment scores below 30%.
Human Muscle Fatty Acid Binding Protein (H-FABP) 
with 133 aa (PDB code: 1HMT) binds several LCFAs, as 
with the case of target sequences. The functional characteris-
tics similarity between H-FABP and CD36 [127–279 aa], the 
high-resolution of 1HMT with resolution value of 1.4 Å, and 
the results of a study on reversible binding of LCFAs to puri-
fied fat, the adipose CD36 homolog,13 are the why 1HMT 
was selected as a template.
Comparative modeling and structure refinement. The 
theoretical structure of CD36-FA binding site of 1HMT was 
generated using MODELLER-9v1116 by comparative model-
ing of protein structure prediction.
MODELLER implements comparative protein structure 
modeling by satisfaction of spatial restraints. The program was 
designed to use as many different types of information about 
the target sequence as possible.17 MODELLER generated 
several preliminary models which were ranked based on their 
DOPE scores. Several models with the lowest DOPE scores 
were selected and the stereochemical properties of each one 
were assessed by PROCHECK,18 and Errat.19 The model is 
visualized by Discovery Studio Software.20
PROCHECK analysis of the model was performed 
to determine whether the residues were falling in the most 
favored region of the Ramachandran plot.21 The model with 
the least number of residues in the disallowed region was 
selected for further studies. Errat was used for verification of 
evaluating the progress of crystallographic model building 
and refinement.
Calculation of root mean square deviation (RMSD) 
was performed by UCSF Chimera program.22 It determines 
the best-aligning pair of chains between template and match 
structure.
Comparison between secondary structures of target/
template. Secondary structures of CD36 [127–279aa] and 
1HMT were compared using UCSF Chimera program, which 
gives the consensus sequence.
Prediction of secondary structure. PSIPRED,23 
BetaTPred2,24 and GAMMAPRED25 servers were used to 
predict the secondary structure of the target sequence, recog-
nize helix, and strand and coil regions.
Expasy ProtParam server26 determined the percentage 
of amino acid components essential for interpretation of the 
predicted units of secondary structure.
Functional site prediction. Q-Sitefinder server27 
was used to predict binding site residues in modeled target 
sequences. Ten binding sites were predicted for the target 
sequence. These binding sites were further compared to the 
active sites of the template.
Pocket-Finder28 was used to compare pocket detection 
with our ligand binding site detected by Q-sitefinder.
Results
Qualitative study of predicted model for CD36-FA 
binding site. The generated model was confirmed using 
NIH SAVeS (Structural Analysis and Verification Server) 
(Fig. 1) and the accuracy was judged by PROCHECK analy-
sis, which showed that 96.4% of the residues were found in 
allowed regions of the Ramachandran Plot (Fig. 2). Among 
the 138 residues, 128 residues were found in the most favored 
region, 5 in the additionally allowed region, 2 in the gener-
ously allowed region, and 3 residues in the disallowed region 
(Table 2).
Overall quality factor was calculated with Errat analysis 
and the modeled structure was found to have 53.103% quality 
factor. The RMSD between 102 atom pairs of predicted model 
and template is 0.605 Å (Fig. 3).
Table 1. target protein and template protein considered for the study.
TARgET PRoTEin uniPRoT iD LEngTH PDB iD
fatty acid-binding  
protein 2, liver
P81400 126 aa. 2ftB
fatty acid-binding  
protein, brain
o15540 132 aa. 1fE3
fatty acid-binding  
protein, heart
P05413 133 aa. 1hms
fatty acid-binding  
protein, muscle
P41509 134 aa. 2flJ
14 kda fatty acid- 
binding protein
P29498 133 aa. 1Vyg
fatty acid-binding  
protein, adipocyte
P04117 132 aa. 1 adl
fatty acid-binding  
protein homolog 1
Q02970 133 aa. 1o8V
Epidermal-typefatty  
acid-binding protein
Q01469 135 aa. 1B56
fatty acid-binding  
protein 2
P02693 132 aa. 2ifB
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Secondary structure prediction. Table 3 shows the data 
obtained from the Expasy’s ProtParam server, giving the per-
centage of amino acid components of the target sequence. The 
high percentage of proline, glycine, aspartic acid, and aspar-
agine in the CD36 [127–279 aa] demonstrates the dominance 
of beta turns in this molecule compared with gamma turns, 
which are clear in the results of BetaTPred2 and GammaPred 
servers (Fig. 4).
PsiPred server revealed 19.6% residues in the formation 
of two helices, 23.52% residues in six strands, and 56.88% res-
idues in formed coils. Comparison of match CD36 [127–279 
aa] and 1HMT shows a strong similarity of their secondary 
structure, with the exception of a short part in the upstream, 
the sequence length of beta sheets, and parts of gaps (Fig. 5).
Using the UCSF Chimera program, we were able to 
determine 22 consensus residues between the matched CD36 
[127–279 aa] and 1HMT (Fig. 5).
Determination of CD36 [127–279aa] active site. Among 
the proposed sites obtained by Q-SiteFinder, and based on the 
comparison of CD36 [127–279 aa] with the FA binding site of 
1HMT, (CD36-S1) site was identified as: ALA143, SER146, 
TYR149, GLN152, PHE153, LEU158, ILE162, ASN163, 
LYS164, LYS166, SER167, SER168, PHE170, GLN171, 
VAL172, THR174, ARG176, LEU189, PRO191, PRO193, 
THR195, THR196, THR197, VAL198, TYR212, LYS213, 
VAL214, PHE215, LYS218, ASP219, TYR238, GLU240, 
SER253, PRO255, LEU264, PHE266, SER274, TYR276 
(Fig. 6).
(CD36-S1 site) occupies a volume of 719 Å3 with 5.16% 
of the total volume of target sequence.
Pocket-Finder, which uses the same interface as 
Q-SiteFinder, predicted that the site volume of the pocket has 
1255 Å3 with 9% of the total volume of the target sequence. 
This site contains the same residues of (CD36-S1 site) and the 
complementary residues that are crucial for the building of 
the pocket.
Discussion
In this study, we determined the 3D model of CD36-FA 
binding site. Qualitative analysis of the predicted model pre-
sented the best quality model, which was reliable as 97.8% 
residues were in allowed regions according to Ramachandran 
Figure 1. modeled structure of cd36 [127–279 aa] where α-helices 
have been represented by red color, strands by cyan, loops in green 
and the gray color indicates the coil.
























Figure 2. ramachandran plot graphical.
Table 2. ramachandran plot calculations of cd36 [127–279 aa].
RAmACHAnDRAn PLoT STATiSTiCS moDELED  
SEquEnCE
% amino acid in most favored regions 92.8
% amino acid in additional allowed regions 3.6
% amino acid in generously allowed regions 1.4
% amino acid in disallowed regions 2.2
 
Figure 3. superposed structure of target (tan) and template (cyan).
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plot statistics results. Errat analysis showed that the predicted 
3D structure is stable, in addition to the high similarity in 
the 3D structure determined by the RMSD of superimposed 
template-target.
The secondary structure prediction, using Psipred, vali-
dated the target model based on their 2D structure.
The comparison between the predicted 2D structure 
and that obtained by UCSF Chimera program confirm the 
similarity of the 2D structure category in certain portions and 
their location in the same position and was refer to by the helix 
[140–164 aa] and the three strands [225–230 aa], [262–267 
aa], and [273–279 aa]. According to the functional site predic-
tion mentioned above, we were able to determine that these 
six residues (Ser146, Ser168, Thr174, Leu189, Leu264, and 
Tyr276) are involved in the formation of the active site.
In this paper, we were interested in the (CD36-S1) site, 
which is probably the most active site for fixing LCFA. How-
ever, it is necessary to take into consideration the importance 
of other active sites predicted in the interaction between 
LCFA and CD36.
Recently, Kudal et al. showed that Lys164 of CD36 plays 
a critical role in uptake of LCFAs.28 In our studies, and after 
alignment analysis of the target and template, we were able 
to show that Lys164 is semi-conserved (data not shown). On 
the other hand, the position of Arg273 in the last strand sug-
gests a role of this amino acid in CD36. We could conclude 
that besides the six consensus residues mentioned above, the 
Arg273 and Lys164, which are semi-conserved, are probably 
involved in binding FAs by the CD36 protein.
In the generated model, two parts were detected. The 
first one is composed of alpha-helices with hydrophobic 
characteristics allowing a high affinity for LCFAs. This part 
must be considered as the main portal of the CD36 receptor to 
LCFAs. The second part is considered a central barrel where 
all the functional sites predict by Q- Sitefinder are co-local-
izing. This part of CD36-FA binding site contains a cavity 
which is characterized by the presence of a hydrophobic seg-
ment [184–204 aa] and is probably associated with the cell 
membrane.29
Conclusion
This paper describes for the first time a 3D homology modeling 
of transmembrane protein CD36 using a cytoplasmic protein 
template. The 3D structure prediction of CD36-FA binding 
site is a first step towards understanding the role played by 
this receptor in lipid metabolism and development of differ-
ent pathologies. The predicted functional sites and the precise 
localization of the essential residues in LCFAs binding will 
allow us to start docking analysis and confirm the precise role 
of these CD36 residues in FA binding.
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Figure 4. (a) Predicted beta turn residues and (b) gamma turn residues 
of cd36 [127–279 aa].
3D structure prediction on receptor CD36
373Bioinformatics and Biology insights 2013:7
Contributed to the writing of the manuscript: AI, OS. Agree 
with manuscript results and conclusions: AM, NAA. Jointly 
developed the structure and arguments for the paper: AI, AK. 
Made critical revisions and approved final version: AK, AI.All 
authors reviewed and approved of the final manuscript.
DiSCLoSuRES AnD ETHiCS
As a requirement of publication the authors have provided signed confirmation of their 
compliance with ethical and legal obligations including but not limited to compliance 
with icmJE authorship and competing interests guidelines, that the article is neither 
under consideration for publication nor published elsewhere, of their compliance with 
legal and ethical guidelines concerning human and animal research participants (if 
applicable), and that permission has been obtained for reproduction of any copy-
righted material. this article was subject to blind, independent, expert peer review. 
the reviewers reported no competing interests.
REFEREnCES
 1. Hamilton JA, Johnson RA, Corkey B, Kamp F. Fatty acid transport: the diffusion 
mechanism in model and biological membranes. J Mol Neurosci. 2001;16(2–3): 
99–108; discussion 151–7.
 2. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning 
of a rat adipocyte membrane protein implicated in binding or transport of long- 
chain fatty acids that is induced during preadipocyte differentiation. Homology 
with human CD36. J Biol Chem. 1993;268(24):17665–8.
 3. Hwang EH, Taki J, Yasue S, et al. Absent myocardial iodine-123i-BMIPP uptake 
and platelet/monocyte CD36 deficiency. J Nucl Med. 1998;39(10):1681–4.
 4. Tanaka T, Okamoto F, Sohmiya K, Kawamura K. Lack of myocardial iodine-123 
15-(p-iodiphenyl)-3-r, s-methylpentadecanoic acid (BMIPP) uptake and cd36 
abnormality. Japanese Circ J. 1997;61(8):724–5.
 5. Ma X, Bacci S, Mlynarski W, et al. A common haplotype at the cd36 locus is 
associated with high free fatty acid levels and increased cardiovascular risk in 
Caucasians. Hum Mol Genet. 2004;13(19):2197–205.
 6. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. 
Defective uptake and utilization of long chain fatty acids in muscle and adipose 
tissues of CD36 knockout mice. J Biol Chem. 2000;275(42):32523–9.
 7. Hajri T, Ibrahimi A, Coburn CT, et al. Defective fatty acid uptake in the spon-
taneously hypertensive rat is a primary determinant of altered glucose metabo-
lism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem. 2001;276(26): 
23661–6.
 8. Poirier H, Degrace P, Niot I, Bernard A, Besnard P. Localization and regulation 
of the putative membrane fatty-acid transporter (fat) in the small intestine. Eur J 
Biochem. 1996;238(2):368–73.
 9. Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A, 
Glatz JF. Cellular fatty acid transport in heart and skeletal muscle as facilitated 
by proteins. Lipids. 1999;34 Suppl:S169–75.
 10. Abumrad N, Coburn C, Ibrahimi A. Membrane proteins implicated in long-
chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim 
Biophys Acta. 1999;1441(1):4–13.
 11. Guthmann F, Haupt R, Looman AC, Spener F, Rüstow B. Fatty acid translocase/ 
cd36 mediates the uptake of palmitate by type ii pneumocytes. Am J Physiol. 
1999;277(1 Pt 1):L191–6.
 12. Lobo MV, Huerta L, Ruiz-Velasco N, et al. Localization of the lipid receptors 
cd36 and cla-1/sr-bi in the human gastrointestinal tract: Towards the identifica-
tion of receptors mediating the intestinal absorption of dietary lipids. J Histochem 
Cytochem. 2001;49(10):1253–60.
 13. Baillie AG, Coburn CT, Abumrad NA. Reversible binding of long-chain fatty acids 
to purified fat, the adipose cd36 homolog. J Membr Biol. 1996;153(1):75–81.
 14. Apweiler R, Bairoch A, Wu CH, et al. Uniprot: the universal protein knowl-
edgebase. Nucleic Acids Res. 2004;32(Database issue):D115–9.
 15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment 
search tool. J Mol Biol. 1990;215(3):403–10.
 16. Sali A, Blundell TL. Comparative protein modeling by satisfaction of spatial 
restraints. J Mol Biol. 1993;234(3):779–815.
 17. Fiser A, Do RK, Sali A. Modeling of loops in protein structures. Protein 
Sci. 2000;9(9):1753–73.
 18. Laskowski RA, MacArthur MW, Moss DS, Thornton J M. PROCHECK: a 
program to check the stereochemical quality of protein structures. J Appl Cryst. 
1993;26(2):283–91.
 19. Colovos C, Yeates TO. Verification of protein structures: Patterns of non bonded 
atomic interactions. Protein Sci. 1993;2(9):1511–9.
 20. Gao YD, Huang JF. An extension strategy of Discovery Studio 2.0 for non-
bonded interaction energy automatic calculation at the residue level. Dongwuxue 
Yanjiu. 2011;32(3):262–6.
 21. Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of poly-
peptide chain configurations. J Mol Biol. 1963;7:95–9.
 22. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera–a visualiza-
tion system for exploratory research and analysis. J Comput Chem. 2004;25(13): 
1605–12.
 23. Jones DT. Protein secondary structure prediction based on position-specific 
scoring matrices. J Mol Biol. 1999;292(2):195–202.
 24. Kaur H, Raghava GP. A neural-network based method for prediction of gamma-
turns in proteins from multiple sequence alignment. Protein Sci. 2003;12(5): 
923–9.
 25. Kaur H, Raghava GP. Prediction of turns in proteins from multiple alignments 
using neural network. Protein Sci. 2003;12(3):627–34.
 26. Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis 
tools on the expasy server. In: Walker J, ed. The Proteomics Protocols Handbook. 
Humana Press. 2005:571–607.
 27. Laurie AT, Jackson RM. Q-SiteFinder: an energy-based method for the predic-
tion of proteinligand binding sites. Bioinformatics. 2005;21(9):1908–16.
 28. Kuda O, Pietka TA, Demianova Z, et al. Sulfo-N-succinimidyl oleate (SSO) 
inhibits fatty acid uptake and signaling for intracellular calcium via binding 
CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by 
macrophages. J Biol Chem. May 31, 2013;288(22):15547–55.
 29. Puente Navazo MD, Daviet L, Ninio E, McGregor JL. Identification on human 
cd36 of a domain (155–183) implicated in binding oxidized low-density lipopro-
teins (ox- LDL). Arterioscler Thromb Vasc Biol. 1996;16(8):1033–9.
Figure 6. Predicted site1, ligand colored in yellow and site residues in 
brown.
